Netherlands· NL-b38ffb837f9c

Ticagrelor Aurobindo 60 mg, filmomhulde tabletten

A ticagrelor product containing ticagrelor, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC B01AC24

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ticagrelorAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ticagrelor is registered in 18 of 19 countries.

Countries holding a registration under ATC B01AC24 (ticagrelor), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search ticagrelor products by name

Ticagrelor · ATC B01AC24

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ticagrelor costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), the median price runs from $0.68 in United States to $1.97 in Spain — a ×2.9 gap.

5 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Ticagrelor · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

ES Spain$1.97
CH Switzerland$1.80
IT Italy$0.94
FR France$0.77
US United States$0.68 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TICAGRELOR
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: B01AC24
ATC class: Ticagrelor
Defined daily dose: 0.18 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
132868

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

529 interactions on record for ticagrelor.

Graded by severity as the source publishes them — 76 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ticagrelor against other medicines How interaction checks work

Ticagrelor · interactions on record

529 records

76 severe
354 moderate
60 minor

Most severe, free to view

LonafarnibA16AX20severe
DalteparinB01AB04severe
EnoxaparinB01AB05severe
DanaparoidB01AB09severe

39 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ticagrelor in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticagrelor products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Ticagrelor, Ticagrelor Accord
Belgium · Ticagrelor Ab, Ticagrelor Eg
Bulgaria · ?????????? Accord, Tilobrastil
Cyprus · Brirem, Lacrat
Czechia · Atirabo, Atixarso
Germany · Ticabril, Ticagrelor
Denmark · Lacrat, Ticagrelor Accord
Estonia · Agtileq, Atirabo
Spain · Lacrat, Ticagrelor Abdi
Finland · Ticagrelor Accord, Ticagrelor Avansor
France · Ticagrelor Accord, Ticagrelor Arrow
United Kingdom (Northern Ireland) · Bellaflow, Clariflow
Greece · Agilinta, Atixarso
Croatia · Atixarso, Greccas
Hungary · Atirabo, Atixarso
Ireland · Ticagrelor Accord, Ticagrelor Bluefish
Iceland · Brilique, Ticagrelor Krka
Italy · Auretica, Ticagrelor
Liechtenstein · Brilique
Lithuania · Atirabo, Atixarso
Luxembourg · Ticagelor Eg (Eurogenerics) Nv, Ticagrelor Eg
Latvia · Atirabo, Atixarso
Malta · Brirem, Croalcril
Norway · Brilique, Ticagrelor Accord
Poland · Atirabo, Atixarso
Portugal · Brirem, Lacrat Mg
Romania · Atixarso, Croalcril
Sweden · Auretica, Ecugra
Slovenia · Atixarso, Lacrat
Slovakia · Atirabo, Atixarso

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cfb6a106-8d7f-4402-8e48-8128c47fcd68
GET /v1/drugs/cfb6a106-8d7f-4402-8e48-8128c47fcd68?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132868_smpc.pdf",
  "strength": null,
  "atc_label": "Ticagrelor",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132868",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "TICAGRELOR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132868.pdf",
  "authorised_at": "2025/05/28",
  "procedure_number": "PT/H/2597/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132868",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ticagrelor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console